Silva Pharmaceuticals Limited (DSE:SILVAPHL)

Silva Pharmaceuticals Income Statement

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	356.99	383.65	599.66	716.87	778.67	799.25
Revenue Growth (YoY)	-28.36%	-36.02%	-16.35%	-7.94%	-2.57%	4.71%
Cost of Revenue	264.22	283.13	437.91	487.58	492.89	486.26
Gross Profit	92.76	100.51	161.75	229.29	285.78	312.99
Selling, General & Admin	224.66	221.52	209.99	185.61	175.07	171.85
Other Operating Expenses	-	-	-	-1.1	-1.05	-0.94
Operating Expenses	224.66	221.52	209.99	184.51	174.02	170.91
Operating Income	-131.89	-121.01	-48.25	44.78	111.76	142.09
Interest Expense	-5.13	-4.48	-4.38	-3.61	-4.71	-2.78
Interest & Investment Income	4.43	5.34	5.17	9.45	9.67	12.05
Other Non Operating Income (Expenses)	0.29	0.58	0.96	-0.26	-0.05	-0.02
Pretax Income	-132.29	-119.58	-46.5	50.36	116.67	151.35
Income Tax Expense	13.12	13.37	17.99	17.29	14.41	31.49
Net Income	-145.41	-132.95	-64.48	33.08	102.26	119.85
Net Income to Common	-145.41	-132.95	-64.48	33.08	102.26	119.85
Net Income Growth	-	-	-	-67.65%	-14.68%	0.77%
Shares Outstanding (Basic)	137	137	137	137	137	137
Shares Outstanding (Diluted)	137	137	137	137	137	137
EPS (Basic)	-1.07	-0.97	-0.47	0.24	0.75	0.88
EPS (Diluted)	-1.07	-0.97	-0.47	0.24	0.75	0.88
EPS Growth	-	-	-	-67.65%	-14.68%	0.92%
Free Cash Flow	3.33	6.49	-29.57	-16.7	-16.8	82.22
Free Cash Flow Per Share	0.02	0.05	-0.22	-0.12	-0.12	0.60
Dividend Per Share	-	-	0.100	0.100	0.300	0.500
Dividend Growth	-	-	-	-66.67%	-40.00%	-
Gross Margin	25.99%	26.20%	26.97%	31.99%	36.70%	39.16%
Operating Margin	-36.95%	-31.54%	-8.05%	6.25%	14.35%	17.78%
Profit Margin	-40.73%	-34.65%	-10.75%	4.61%	13.13%	15.00%
Free Cash Flow Margin	0.93%	1.69%	-4.93%	-2.33%	-2.16%	10.29%
EBITDA	-76.84	-63.18	10.54	107.29	174.33	207.38
EBITDA Margin	-21.52%	-16.47%	1.76%	14.97%	22.39%	25.95%
D&A For EBITDA	55.06	57.83	58.79	62.51	62.57	65.29
EBIT	-131.89	-121.01	-48.25	44.78	111.76	142.09
EBIT Margin	-36.95%	-31.54%	-8.05%	6.25%	14.35%	17.78%
Effective Tax Rate	-	-	-	34.33%	12.35%	20.81%
Advertising Expenses	-	5.37	3.82	3.81	5.92	20.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.